EternaTear
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $7.1M
Investors
- 6
About EternaTear
EternaTear, Inc.EternaTear, Inc. was founded in 2018 and is headquartered in Raleigh, US. The company focuses on creating artificial tear solutions for dry eye syndrome. The founder, Tim W, has a background that includes previous entrepreneurial ventures.EternaTear™ specializes in developing advanced artificial tear solutions designed to address the complexities of dry eye syndrome. The flagship product, EternaTear™, utilizes a novel mechanism to mimic the composition and function of natural tears, providing longer-lasting relief than conventional over-the-counter eye drops.EternaTear™ generates revenue through direct sales of its flagship product, EternaTear™, to healthcare providers and pharmacies that serve patients with dry eye syndrome. The company partners with eye care professionals who recommend the product, facilitating a direct-to-consumer model along with possible wholesale arrangements for broader distribution. The company is designing additional products aimed at further improving dry eye treatment, with details on release dates to be announced. Furthermore, EternaTear intends to penetrate international markets beyond North America, targeting specific regions for expansion by the end of 2023.
Who invested in EternaTear
6 investors across 2 rounds
See all investors in EternaTear
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EternaTear
Who invested in EternaTear?
EternaTear has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EternaTear raised?
EternaTear has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did EternaTear last raise money?
EternaTear's most recent round on record is a Series A, in Oct 2020.
What does EternaTear do?
EternaTear is a pharmaceuticals company.
Where is EternaTear headquartered?
EternaTear is headquartered in Raleigh, US.
Which VCs invest in companies like EternaTear?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at EternaTear's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like EternaTear? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.